UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer

Nature reviews. Urology, 2021-02, Vol.18 (2), p.104

2021

Volltextzugriff (PDF)

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

European urology, 2016-08, Vol.70 (2), p.358-364

2016

Volltextzugriff (PDF)

The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer

The Journal of urology, 2024-07, p.101097JU0000000000004160

2024

Volltextzugriff (PDF)

The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221094879-17588359221094879

2022

Volltextzugriff (PDF)

Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations

Cancers, 2023-06, Vol.15 (12), p.3167

2023

Volltextzugriff (PDF)

Improving adherence and health outcomes in testicular cancer survivors using a mobile health-based intervention: A mixed-methods pilot study

Digital health, 2023-01, Vol.9, p.20552076231167002-20552076231167002

2023

Volltextzugriff (PDF)

Description of a Multi-faceted COVID-19 Pandemic Physician Workforce Plan at a Multi-site Academic Health System

Journal of general internal medicine : JGIM, 2021-05, Vol.36 (5), p.1310-1318

2021

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer

Clinical genitourinary cancer, 2019-02, Vol.17 (1), p.38-45

2019

Volltextzugriff (PDF)

Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada

Current oncology (Toronto), 2022-10, Vol.29 (10), p.7587-7597

2022

Volltextzugriff (PDF)

Contemporary Treatment of Metastatic Renal Cell Carcinoma

Oncology Reviews, 2016-07, Vol.10 (1), p.295-295

2016

Volltextzugriff (PDF)

Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer

Clinical genitourinary cancer, 2018-04, Vol.16 (2), p.130-134

2018

Volltextzugriff (PDF)

High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience

Canadian Urological Association journal, 2024-03, Vol.18 (3), p.E73-E79

2024

Volltextzugriff (PDF)

Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers

European urology oncology, 2023-12, Vol.6 (6), p.597-603

2023

Volltextzugriff (PDF)

Real-world Outcomes in Advanced Urothelial Cancer and the Role of Neutrophil to Lymphocyte Ratio

Clinical genitourinary cancer, 2018-06, Vol.16 (3), p.e637-e644

2018

Volltextzugriff (PDF)

Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection

Canadian Urological Association journal, 2020-08, Vol.14 (8), p.E373-E382

2020

Volltextzugriff (PDF)

Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic

Canadian Urological Association journal, 2020-05, Vol.14 (5), p.E154-E158

2020

Volltextzugriff (PDF)

Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel

Canadian Urological Association journal, 2018-08, Vol.12 (8), p.E365-E372

2018

Volltextzugriff (PDF)

Options in metastatic urothelial cancer after first-line therapy

Current opinion in supportive & palliative care, 2015-09, Vol.9 (3), p.255

2015

Volltextzugriff (PDF)

Case - "Burned-out" testicular tumor: A rare entity with diagnostic dilemma

Canadian Urological Association journal, 2022-11, Vol.16 (11), p.E572-E574

2022

Volltextzugriff (PDF)

The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study

Bladder cancer, 2018-04, Vol.4 (2), p.185-194

2018

Volltextzugriff (PDF)

MP77-13 DOWNSTAGING OF PRIMARY VS. SECONDARY MUSCLE INVASIVE BLADDER CANCER AFTER CYSTECTOMY AND ITS ASSOCIATION WITH SURVIVAL

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift

Nature reviews. Clinical oncology, 2024-04, Vol.21 (4), p.255-256

2024

Volltextzugriff (PDF)

Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-12-12

2022

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Urology & Nephrology
(23)
Humans
(20)
Oncology
(20)
Bladder Cancer
(11)
Care And Treatment
(11)
Male
(11)
Aged
(9)
Middle Aged
(9)
Retrospective Studies
(9)
Cancer
(8)
Metastasis
(8)
Chemotherapy
(7)
Prostate Cancer
(7)
Treatment Outcome
(7)
Urothelial Carcinoma
(7)
Aged, 80 And Over
(6)
Antineoplastic Agents - Therapeutic Use
(6)
Canada
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(29)
Canadian Urological Association Journal
(17)
The Journal Of Urology
(11)
Clinical Genitourinary Cancer
(7)
Bladder Cancer
(2)
European Urology
(2)
European Urology Oncology
(2)
The Prostate
(2)
Cancer Research
(1)
Cancers
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer

The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy

Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations

Improving adherence and health outcomes in testicular cancer survivors using a mobile health-based intervention: A mixed-methods pilot study

Description of a Multi-faceted COVID-19 Pandemic Physician Workforce Plan at a Multi-site Academic Health System

Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer

Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada

Contemporary Treatment of Metastatic Renal Cell Carcinoma

Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer

High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience

Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial

Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers

Real-world Outcomes in Advanced Urothelial Cancer and the Role of Neutrophil to Lymphocyte Ratio

Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection

Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic

Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy

Options in metastatic urothelial cancer after first-line therapy

Case - "Burned-out" testicular tumor: A rare entity with diagnostic dilemma

The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study

MP77-13 DOWNSTAGING OF PRIMARY VS. SECONDARY MUSCLE INVASIVE BLADDER CANCER AFTER CYSTECTOMY AND ITS ASSOCIATION WITH SURVIVAL

Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift

Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences

Suchergebnisse filtern